Purple Biotech Ltd. (PPBT.TA)
ILA 6.9
(-4.17%)
ILA 6.9
(-4.17%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | -22.46 Million USD | -99.91% |
| 2022 | 22.6 Million USD | 26.03% |
| 2021 | 17.93 Million USD | 30.01% |
| 2020 | 13.79 Million USD | 57.61% |
| 2019 | 8.75 Million USD | -0.84% |
| 2018 | 8.82 Million USD | -26.82% |
| 2017 | 12.06 Million USD | 67.91% |
| 2016 | 7.18 Million USD | 76.53% |
| 2015 | 4.06 Million USD | -21.46% |
| 2014 | 5.18 Million USD | 342.82% |
| 2013 | 1.17 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 4.46 Million USD | -28.74% |
| 2024 Q2 | 3.25 Million USD | -22.57% |
| 2023 Q4 | 6.26 Million USD | 9.05% |
| 2023 FY | 20.25 Thousand USD | -99.91% |
| 2023 Q1 | 5.12 Million USD | -22.41% |
| 2023 Q2 | 5.13 Million USD | 0.25% |
| 2023 Q3 | 5.74 Million USD | 11.92% |
| 2022 Q3 | 5.08 Million USD | 41.53% |
| 2022 Q4 | 6.6 Million USD | 29.92% |
| 2022 FY | 22.6 Million USD | 26.03% |
| 2022 Q1 | 7.33 Million USD | 59.89% |
| 2022 Q2 | 3.59 Million USD | -51.03% |
| 2021 Q4 | 4.58 Million USD | 43.46% |
| 2021 Q1 | 6.67 Million USD | 3084.73% |
| 2021 Q3 | 3.19 Million USD | -11.76% |
| 2021 FY | 17.93 Million USD | 30.01% |
| 2021 Q2 | 3.62 Million USD | -45.71% |
| 2020 Q4 | 209.5 Thousand USD | -5.42% |
| 2020 Q3 | 221.5 Thousand USD | -98.47% |
| 2020 Q2 | 14.44 Million USD | 0.0% |
| 2020 Q1 | 14.44 Million USD | 22644.09% |
| 2020 FY | 13.79 Million USD | 57.61% |
| 2019 Q4 | 63.5 Thousand USD | -96.1% |
| 2019 Q2 | 1.78 Million USD | 0.0% |
| 2019 Q1 | 1.78 Million USD | 568.73% |
| 2019 FY | 8.75 Million USD | -0.84% |
| 2019 Q3 | 1.62 Million USD | -8.79% |
| 2018 Q4 | 267 Thousand USD | 0.0% |
| 2018 FY | 8.82 Million USD | -26.82% |
| 2018 Q3 | 267 Thousand USD | -91.29% |
| 2018 Q2 | 3.06 Million USD | 0.0% |
| 2018 Q1 | 3.06 Million USD | -13.08% |
| 2017 Q3 | 3.52 Million USD | 16.16% |
| 2017 FY | 12.06 Million USD | 67.91% |
| 2017 Q4 | 3.52 Million USD | 0.0% |
| 2017 Q1 | 3.03 Million USD | -33.34% |
| 2017 Q2 | 3.03 Million USD | 0.0% |
| 2016 Q2 | 1.57 Million USD | 0.0% |
| 2016 Q4 | 4.55 Million USD | 0.0% |
| 2016 FY | 7.18 Million USD | 76.53% |
| 2016 Q1 | 1.57 Million USD | 26.42% |
| 2016 Q3 | 4.55 Million USD | 188.32% |
| 2015 FY | 4.06 Million USD | -21.46% |
| 2015 Q4 | 1.24 Million USD | 4.69% |
| 2015 Q3 | 1.19 Million USD | 13.94% |
| 2015 Q2 | 1.04 Million USD | 64.88% |
| 2015 Q1 | 635 Thousand USD | -60.16% |
| 2014 Q3 | 1.18 Million USD | -33.61% |
| 2014 Q4 | 1.59 Million USD | 34.74% |
| 2014 Q2 | 1.78 Million USD | 32.79% |
| 2014 FY | 5.18 Million USD | 342.82% |
| 2014 Q1 | 1.34 Million USD | 332.9% |
| 2013 Q2 | 213 Thousand USD | 85.22% |
| 2013 FY | 1.17 Million USD | 0.0% |
| 2013 Q4 | 310 Thousand USD | -84.18% |
| 2013 Q3 | 1.95 Million USD | 819.72% |
| 2013 Q1 | 115 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Matricelf Ltd | 11.78 Million ILA | 290.641% |